NOS2 and asthma: Similar findings were obtained with the activator BAY 60-2777 in a murine model of asthma, in which treatment with this drug normalized the expression levels of iNOS and sGC in the lungs triggering an anti-inflammatory effect (Baldissera et al., 2016).